ALBA 4D

Hyperthermia (HT), heating tumours in the range 41-43°C, is a powerful radio and chemosensitizer. The effectiveness of hyperthermia as well as its safety, in combination with radiotherapy and chemotherapy, has already been proven in phase III clinical trials [1, 2,], particularly in patients with very large or very advanced stages of cancer and recurrent tumours. Hyperthermia enhances the effect of radiotherapy on the tumour, without additional toxicity for healthy tissues, thanks to three synergistic mechanisms:

The ALBA 4D system has a RADAR-based technology unit consisting of a multi-beam phased array of 4 waveguide antennas working at 70 MHz radiating 4 beams independently modulated in phase and amplitude to focus the energy onto the target at any depth and location in the pelvis, abdomen and extremities.

The motorized controlled movement of the gantry and the waveguide antennas towards the patient allows ALBA 4D to adapt its mechanical configuration to different patient sizes and anatomies, thus enhancing treatment efficiency and patient comfort.

Embedded laser pointing system for optimal cranio-caudal, dorso-ventral and lateral patient positioning. This allows for both reproducibility of the antennas/patient positioning throughout all the treatments, as well as collimation of the antennas/patient configuration with ALBA easyPLAN and PLAN2heat simulation software.

Dedicated software to ease treatment workflow, assist the user in planning treatment and correct settings and enhance treatment quality.